Therapeutic Asset Ratings
18,153 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Obeticholic Acid
Primary Biliary Cholangitis
Intercept Pharmaceuticals
P3
BB
(68)
Olaparib
Fallopian Tube Transitional Cell Carcinoma
National Cancer Institute (NCI)
P3
BB
(68)
Olaparib
Pancreatic Adenocarcinoma
Lantern Pharma Inc.
P3
BB
(68)
Olaparib
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)
P3
BB
(68)
Olaparib
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)
P3
BB
(68)
Olaparib
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)
P3
BB
(68)
Orelabrutinib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P3
BB
(68)
Orforglipron
Obesity Disorder
Eli Lilly and Company
P3
BB
(68)
Oxaliplatin
Extranodal Nasal NK/T Cell Lymphoma
CStone Pharmaceuticals
P3
BB
(68)
Oxaliplatin
Gastroesophageal Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P3
BB
(68)
Oxaliplatin
Peritoneal Carcinomatosis
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
P3
BB
(68)
Oxaliplatin
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P3
BB
(68)
Oxaliplatin
Secondary Malignant Neoplasm
Sixth Affiliated Hospital, Sun Yat-sen University
P3
BB
(68)
Palazestrant
Her2-Receptor Negative Breast Cancer
Olema Pharmaceuticals, Inc.
P3
BB
(68)
Pirtobrutinib
B-Cell Non-Hodgkin Lymphoma
Nurix Therapeutics, Inc.
P3
BB
(68)
Prednisolone
Prostate Neoplasm
Eli Lilly and Company
P3
BB
(68)
Prednisone
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(68)
Prednisone
Adult Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(68)
Repinatrabit
Phenylketonuria
Otsuka Pharmaceutical Development & Commercialization, Inc.
P3
BB
(68)
Seladelpar
Primary Biliary Cholangitis
Gilead Sciences
P3
BB
(68)
Selinexor
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Chengdu Zenitar Biomedical Technology Co., Ltd
P3
BB
(68)
Sirolimus
Chronic Myeloid Leukemia
Masonic Cancer Center, University of Minnesota
P3
BB
(68)
Tacrolimus
Graft Versus Host Disease
City of Hope Medical Center
P3
BB
(68)
Tacrolimus
Myelodysplastic Syndrome
City of Hope Medical Center
P3
BB
(68)
Tacrolimus
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
P3
BB
(68)
Showing 1851 to 1875 of 18,153 assets
Previous
Page 75 of 727
Next